29 Sept 2026, 16:57
Company Administration—
Announcement history available from 1 August 2025
| Date / Time | Heading | Type | MS | Report Codes | |
|---|---|---|---|---|---|
| 29 Sept 2026, 16:57 | Appendix 4G | Company Administration | — | 03025 | |
| 29 Sept 2026, 16:57 | Corporate Governance Statement | Company Administration | — | 03024 | |
| 29 Sept 2026, 16:55 | 2026 Annual Report | Financial Results | — | 03001, 03002, 03011, 03012, 03013, 03020 | |
| 23 Sept 2026, 09:36 | Stabl-Im Clinical Development Update | Company Update | MS | 11001 | |
| 22 Sept 2026, 09:08 | Notice of AGM and Closing Date for Director Nominations | Meetings & Governance | — | 08006 | |
| 27 Aug 2026, 13:05 | Appendix 4E - Preliminary Final Report | Financial Results | MS | 03003 | |
| 28 July 2026, 14:02 | June 2026 Quarterly Activities Report and Appendix 4C | Quarterly Reports | MS | 19004, 19009 | |
| 16 July 2026, 09:15 | Stabl-Im clinical trial supply milestone achieved | Company Update | MS | 11001 | |
| 25 June 2026, 09:19 | Investor Presentation - Stabl-Im program | Presentations | — | 03026 | |
| 26 May 2026, 14:06 | Change of Registered Office Address | Securities Administration | — | 12002, 12003 | |
| 22 May 2026, 09:36 | CRO Engaged to Advance Stabl-Im Phase 1 Trial | Company Update | MS | 11001 | |
| 30 Apr 2026, 09:38 | March 2026 Quarterly Activities Report and Appendix 4C | Quarterly Reports | MS | 19003, 19008 | |
| 29 Apr 2026, 08:29 | Dr Danielle Meyrick appointed as CEO | Company Administration | MS | 12019 | |
| 5 Mar 2026, 09:29 | Key management changes | Company Administration | — | 12007, 12008 | |
| 24 Feb 2026, 14:53 | Appendix 4D & Half-Year Financial Report to 31 December 2025 | Financial Results | MS | 03004, 03009, 03010, 03015, 03019 | |
| 30 Jan 2026, 08:24 | December 2025 Quarterly Activities Report and Appendix 4C | Quarterly Reports | MS | 19002, 19007 | |
| 2 Jan 2026, 10:29 | Final Director's Interest Notice - John Mathias | Director Interests | — | 02010 | |
| 23 Dec 2025, 17:38 | Ceasing to be a substantial holder | Substantial Holders | — | 02003 | |
| 23 Dec 2025, 09:27 | Becoming a substantial holder - Daniel Tillett | Substantial Holders | — | 02001 | |
| 22 Dec 2025, 11:24 | Second-tranche placement funding completed | Mergers & Acquisitions | — | 03026, 06003, 07001 | |
| 19 Dec 2025, 09:15 | Change of Director's Interest Notice - David Trimboli | Director Interests | — | 02009 | |
| 19 Dec 2025, 09:15 | Change of Director's Interest Notice - Chris Ntoumenopoulos | Director Interests | — | 02009 | |
| 19 Dec 2025, 08:54 | Cleansing Notice | Securities Administration | — | 06018 | |
| 19 Dec 2025, 08:54 | Notification regarding unquoted securities - TRI | Securities Administration | — | 06021 | |
| 19 Dec 2025, 08:43 | Application for quotation of securities - TRI | Securities Administration | — | 06020 | |
| 19 Dec 2025, 08:41 | Notification regarding unquoted securities - TRI | Securities Administration | — | 06021 | |
| 18 Dec 2025, 08:23 | Positive results from US-veteran mental health trial | Company Update | MS | 11001 | |
| 12 Dec 2025, 13:47 | Results of General Meeting | Meetings & Governance | — | 08003 | |
| 9 Dec 2025, 12:54 | Notification of cessation of securities - TRI | Securities Administration | — | 06027 | |
| 5 Dec 2025, 11:15 | Resignation of Director - John Mathias | Company Administration | — | 12001 | |
| 2 Dec 2025, 18:20 | Change of Director's Interest Notice - Tony Keating | Director Interests | — | 02009 | |
| 2 Dec 2025, 18:19 | Change of Director's Interest Notice - John Mathias | Director Interests | — | 02009 | |
| 2 Dec 2025, 18:18 | Change of Director's Interest Notice - David Trimboli | Director Interests | — | 02009 | |
| 2 Dec 2025, 18:17 | Change of Director's Interest Notice - Chris Ntoumenopoulos | Director Interests | — | 02009 | |
| 2 Dec 2025, 18:16 | Cleansing Notice | Securities Administration | — | 06018 | |
| 2 Dec 2025, 18:14 | Notification regarding unquoted securities - TRI | Securities Administration | — | 06021 | |
| 2 Dec 2025, 18:10 | Application for quotation of securities - TRI | Securities Administration | — | 06020 | |
| 21 Nov 2025, 12:24 | Results of Annual General Meeting | Meetings & Governance | — | 08003 | |
| 12 Nov 2025, 10:58 | Update - Proposed issue of securities - TRI | Securities Administration | — | 06013 | |
| 12 Nov 2025, 10:54 | Update - Proposed issue of securities - TRI | Securities Administration | — | 06013 | |
| 12 Nov 2025, 10:33 | Notice of General Meeting & Proxy Form & Access Letter | Meetings & Governance | — | 08004, 08007, 16002 | |
| 5 Nov 2025, 08:48 | TRI Exercises Option to Advance Acquisition of Stabl-Im | Mergers & Acquisitions | MS | 07001 | |
| 31 Oct 2025, 08:37 | September 2025 Quarterly Activities Report and Appendix 4C | Quarterly Reports | MS | 19001, 19006 | |
| 30 Oct 2025, 09:12 | Change in substantial holding - FIL Limited and associates | Substantial Holders | — | 02002 | |
| 29 Oct 2025, 17:29 | Change in substantial holding | Substantial Holders | — | 02002 | |
| 29 Oct 2025, 10:46 | Notification regarding unquoted securities - TRI | Securities Administration | — | 06021 | |
| 27 Oct 2025, 09:17 | Cleansing Notice | Securities Administration | — | 06018 | |
| 27 Oct 2025, 09:17 | Application for quotation of securities - TRI | Securities Administration | — | 06020 | |
| 27 Oct 2025, 09:13 | Application for quotation of securities - TRI | Securities Administration | — | 06020 | |
| 22 Oct 2025, 13:09 | Proposed issue of securities - TRI | Securities Administration | — | 06013 |